Investor Relations

We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.

Stefanie Kutschmann, Good Manufacturing Practice Officer, Frankfurt, Germany

First quarter 2024 results

First quarter 2024 results were reviewed by management during a conference call with the financial community on April 25th. The presentation was followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EST)

Upcoming events

20Jun

2024

Guggenheim Next Decade Bus Tour

Speakers: Brian Foard, Head of Specialty Care & Dietmar Berger, Chief Medical Officer & Head of Development

14:30 EST

Broker Conference

Discover more

26Jun

2024

Stifel Healthcare Summit 2024

Speaker: François Sandre, Head of Europe Commercial Operations Vaccines

13:00 CET

Broker Conference

Discover more

25Jul

2024

Second quarter 2024 results

Second quarter 2024 results will be reviewed by management during a live audio webcast with the financial community on July 25th, 2024. The presentation will be followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EST)

Quarterly Results

Discover more

Press releases

June 21, 2024
Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee
June 21, 2024
Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran
June 20, 2024
Press Release: Sanofi and Biovac spearhead polio vaccine manufacturing capabilities in Africa
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India
Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.

2023 20-F

Presenting our 2023 FORM 20-F.

Contact Our Investor Relations Team

To join the Sanofi front desk,

Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00

To contact the Investor Relations team:

46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com